Excellent presentation as always from these guys, answered all the annoying little questions that some may have been holding onto. In the end the Placebo effect in DMD was very very high in Phase 1 given the passions around the parents and their boys. This was understood, maybe management could have been banged on a bit more along the extreme justifiable passions from the participants and how incredibly powerful the placebo effect can be....
ATL11102 is active, so for mine this means it can remain in the toolbox, but after 22 years management needs a new drug if they are face the investment community . Happy that this current management team can find something new & interesting
Disappointing to see no share market rection, feels like Morissons is working with XEC capital to cap the share price. Love to see them get steamrolled
- Forums
- ASX - By Stock
- Ann: Webinar Presentation - Phase IIb study of avicursen
PER
percheron therapeutics limited
Add to My Watchlist
0.00%
!
1.0¢

Excellent presentation as always from these guys, answered all...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $10.87M |
Open | High | Low | Value | Volume |
1.0¢ | 1.0¢ | 1.0¢ | $727 | 72.68K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 2840316 | 1.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.1¢ | 3323423 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 2840316 | 0.010 |
6 | 5659202 | 0.009 |
4 | 1260267 | 0.008 |
3 | 1642854 | 0.007 |
2 | 3200000 | 0.005 |
Price($) | Vol. | No. |
---|---|---|
0.011 | 3323423 | 6 |
0.012 | 1139598 | 3 |
0.013 | 1000000 | 1 |
0.014 | 2072000 | 4 |
0.015 | 1500000 | 1 |
Last trade - 12.00pm 20/06/2025 (20 minute delay) ? |
Featured News
PER (ASX) Chart |